ProQR Therapeutics (PRQR) Net Income towards Common Stockholders Growth (3y) (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -10.84% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 26.38% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -46.86% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 13.80% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 34.98% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -3.84% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 47.10% |
| 10 | ProQR Therapeutics | 174.11 Mn | 66.54 Mn | - | 12.36% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 12.36% |
| Sep 30, 2025 | 18.15% |
| Jun 30, 2025 | 0.14% |
| Mar 31, 2025 | 11.46% |
| Dec 31, 2024 | 22.15% |
| Sep 30, 2024 | 19.32% |
| Jun 30, 2024 | 46.69% |
| Mar 31, 2024 | 18.21% |
| Dec 31, 2023 | 30.77% |
| Sep 30, 2023 | 25.15% |
| Jun 30, 2023 | -22.99% |
| Mar 31, 2023 | 17.86% |
| Dec 31, 2022 | 12.88% |
| Sep 30, 2022 | -20.29% |
| Jun 30, 2022 | -3.75% |
| Mar 31, 2022 | 0.53% |
| Dec 31, 2021 | -12.16% |
| Sep 30, 2021 | -36.80% |
| Jun 30, 2021 | -29.73% |
| Mar 31, 2021 | -951.71% |
| Dec 31, 2020 | -47.43% |
| Sep 30, 2020 | -983.69% |
| Jun 30, 2020 | 27.93% |
| Mar 31, 2020 | -53.08% |
| Dec 31, 2019 | -29.16% |
| Sep 30, 2019 | -6.12% |
| Jun 30, 2019 | -5.18% |
| Mar 31, 2019 | -18.30% |
| Dec 31, 2018 | -30.06% |
| Sep 30, 2018 | 0.45% |
| Jun 30, 2018 | 2.76% |
| Mar 31, 2018 | 25.99% |
| Dec 31, 2017 | 93.26% |
| Sep 30, 2017 | 26.05% |
| Mar 31, 2017 | 85.57% |
| Dec 31, 2016 | -62.38% |
| Sep 30, 2016 | -113.55% |